Similar articles

• CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.

  Mouridsen HT, Palshof T, Engelsman E, Sylvester R. Mouridsen HT, et al. Eur J Cancer (1965). 1980;Suppl 1:119-23. Eur J Cancer (1965). 1980. PMID: 7032921 Clinical Trial. No abstract available.
• Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.

  Cavalli F, Alberto P, Jungi F, Brunner K, Martz G. Cavalli F, et al. Eur J Cancer (1965). 1980;Suppl 1:125-9. Eur J Cancer (1965). 1980. PMID: 7032922 Clinical Trial. No abstract available.
• Current overview of EORTC clinical trials with tamoxifen.

  Heuson JC. Heuson JC. Cancer Treat Rep. 1976 Oct;60(10):1463-6. Cancer Treat Rep. 1976. PMID: 1021227
• Management of breast cancer.

  Cohen IA, Keller JH, Abate MA. Cohen IA, et al. Clin Pharm. 1982 Nov-Dec;1(6):515-29. Clin Pharm. 1982. PMID: 6192963 Review.
• [Adjuvant chemotherapy in breast cancer].

  Senn HJ. Senn HJ. Dtsch Med Wochenschr. 1981 Nov 27;106(48):1626-30. doi: 10.1055/s-2008-1070568. Dtsch Med Wochenschr. 1981. PMID: 7030686 Review. German. No abstract available.